Biotech Investors & VC Firms in Europe
841 firms in this list, with a median first check of $500K. 192 of them lead rounds. Generated from verified public data and updated continuously.
E44 Ventures
Tel AvivPre-Seed–Seed
10 people
Anthropy Partners
SeattlePre-Seed–Series A
6 people
SIDFUND
AustinSeed$100K
6 people
Ten VC
Menlo ParkPre-Seed–Seed$250K – $1.5M
3 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
JIMCO
St. HelierSeed–Growth
7 people
Ming capital
ShenzhenSeed–Late Stage
6 people
TusStar
BeijingPre-Seed–Growth
7G BioVentures
Burlingame
5 people
Ono Venture Investment, Inc.
South San FranciscoSeed–Series B
6 people
SVG Ventures
Silicon ValleyPre-Seed–Series A
9 people
TO VC
New YorkSeed–Series B
5 people
IAG Capital Partners
CharlestonSeed–Late Stage
3 people
Globivest
Pre-Seed–Series B
5 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
10 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
AddVentures by SCG
BangkokSeed–Late Stage$1.5M – $66M
6 people
Agate Medical Investments LP
Tel-AvivGrowth–Late Stage
Legendary Ventures, Llc.
New York CitySeed–Late Stage
9 people
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
La Caisse
MontréalGrowth–Late Stage
2 people
Avant Bio
New YorkSeed–Growth
6 people
Mammoth Research
Fort WayneSeries A–Growth
9 people
DEFTA Partners
San FranciscoSeed–Series A
5 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.

















































































